To evaluate the effect of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on dementia risk compared with dipeptidyl peptidase-4 inhibitors (DPP-4is) among older adults with type 2 diabetes (T2D).
To examine the cardiovascular safety of dipeptidyl peptidase 4 (DPP-4) inhibitors compared with long-acting insulin or sulfonylurea initiation added to metformin in older people with diabetes in long-term care facilities (LTCFs).
Recommendations for diabetes care in long-term care facilities (LTC) focus on the avoidance of hypoglycemia and symptomatic hyperglycemia. Using continuous glucose monitoring (CGM), we evaluated the current state of glycemia in LTC residents with multiple comorbidities.
To evaluate the impact of statins on delirium incidence in older adults with type 2 diabetes mellitus (T2DM), focusing on hydrophilic versus lipophilic statins and dose-response effects.
Clinical guidance on any issue changes as new medications, interventions, technologies, and best practices emerge and new studies come out. That is certainly true of PALTmed’s Clinical Practice Guidelines (CPGs). The just-revised Diabetes Management in the Post-Acute and Long-Term Care Setting CPG includes...
During the program, Naushira Pandya, MD, CMD, talked about her study, Medication Prescribing for Type 2 Diabetes in the US Long-Term Care Setting: Observational Study. “One reason I wanted to do this study was the high prevalence of diabetes in long-term care,” where, she said, up to 44% of patients have t...